The diabetes devices market is being driven by increasing prevalence of diabetes worldwide, growing geriatric population, and rising awareness about diabetes management. Technological advancements in diabetes devices such as continuous glucose monitoring systems and insulin pumps are also fueling market growth.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Type, Distribution Channel, End Use |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | B Braun Melsungen AG, Bayer AG, Abbott Laboratories, Sanofi, Medtronic Plc, F.Hoffman-La-Ltd., Dexcom,, Lifescan,, Tandem Diabetes Care,, and Companion Medical. |
However, the diabetes devices market is facing challenges due to high cost associated with advanced diabetes devices, lack of reimbursement policies in some regions, and limited access to diabetes care in developing countries. Additionally, stringent regulatory requirements for diabetes devices approval are hindering market growth.